GC, MDGC
GC-MS helps with cancer weight-loss study
Apr 13 2010
Scientists at Trinity College Dublin and New York University explored whether a diet rich in one form of the fat - eicosapentaenoic acid (EPA) - helps prevent the problem.
Esophageal cancer patients were tested in a double-blind randomised test, with both treatment and control groups.
According to the Irish Medical Times, GC-MS techniques - which separates and enables the identification of molecules - were implemented to study immune cells in the lab and revealed a drop in natural killer cells post-operation in the EPA-fed volunteers.
The investigation found patients receiving the nutritional aid experienced no muscle loss at all, while the individuals in the standard test dropped an average of three pounds each.
"Future studies on the health benefits of EPA supplements in cancer patients should be conducted," said lead of the study Professor John Reynolds.
Digital Edition
Chromatography Today - Buyers' Guide 2022
October 2023
In This Edition Modern & Practical Applications - Accelerating ADC Development with Mass Spectrometry - Implementing High-Resolution Ion Mobility into Peptide Mapping Workflows Chromatogr...
View all digital editions
Events
Oct 20 2024 Dresden, Germany
Oct 20 2024 Fort Worth, TX, USA
Oct 21 2024 Dalian, China
Nov 12 2024 Tel Aviv, Israel
Nov 18 2024 Shanghai, China